|

Adebelimab injection Clinical Trials

3 actively recruiting trials

Pipeline

Phase 1: 1Phase 2: 1Phase 1/2: 1

Top Sponsors

  • Xian-Jun Yu1
  • Suzhou Suncadia Biopharmaceuticals Co., Ltd.1
  • Shanghai Hengrui Pharmaceutical Co., Ltd.1

Indications

  • Cancer3
  • Recurrent or Metastatic Cervical Cancer1
  • Tumor, Solid1
  • Advanced Solid Tumors1

Other3 trials

A Trial of SHR-A2102 With Other Antitumor Therapies in Advanced Solid Tumors
Phase 2
SHR-A1811 Combination Regimen for the Treatment of Recurrent or Metastatic Cervical Cancer
Phase 1/2
Study of RGL-270 Single Drug and Combined With Adebelimab in Patients in Patients at High Risk of Recurrence After Radical Treatment of Malignant Solid Tumors
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.